Survival, ventricular arrhythmia, and implantable cardioverter ‐defibrillator usefulness in toxic cardiomyopathy due to substance abuse
ConclusionVA are infrequent in the T-DCM population. The prophylactic ICD benefit was not observed in our cohort. The ideal timing for potential prophylactic ICD implantation in this population needs further studies.
Source: Pacing and Clinical Electrophysiology : PACE - Category: Cardiology Authors: Nicolas Dognin,
Goran Rimac,
Guillaume Domain,
Alexandre Cinq ‐Mars,
Montse Massot,
Pierre Yves Turgeon,
Sacha‐Michelle Dubois‐Sénéchal,
Christine Bourgault,
Joëlle Morin,
Mathieu Bernier,
Jonathan Beaudoin,
Maxime Laflamme,
Eric Char Tags: DEVICES Source Type: research
More News: Arrhythmia | Cardiology | Cardiomyopathy | Dilated Cardiomyopathy | Heart | Heart Failure | Study | Substance Abuse | Substance Abuse Disorders | Toxicology | Ventricular Arrhythmia